Betamethasone Valerate NDC 71205-364

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-364Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0364Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71205-364-15	71205036415	1 TUBE in 1 CARTON (71205-364-15) / 15 g in 1 TUBEMarketed from Nov 20, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Betamethasone Valerate
Generic name (nonproprietary): betamethasone valerate
Active ingredients: Betamethasone valerate — 1.2 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070069
Marketing start: Dec 19, 1985
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 71205-364_e104fc1b-b0dd-4452-84cb-0b90527f25f8SPL ID e104fc1b-b0dd-4452-84cb-0b90527f25f8SPL set ID 2a64b65b-8a49-45ea-9464-2269751c075cRxCUI 197409UNII 9IFA5XM7R2
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205036415 followed by a unit qualifier and the quantity

Package 71205-0364-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 1, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 070069

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 070069
Product	Strength	Form · route	Labeler	Product NDC
Betamethasone Valerate	Betamethasone valerate 1.2 mg/g	OintmentTopical	Cosette Pharmaceuticals, Inc.	0713-0327